Empowering Radiology Experts to Optimize Alzheimer’s Disease (AD) Care
This enduring on-demand activity is designed for neuroradiologists, radiologists, and radiology residents dedicated to enhancing care for patients with Alzheimer’s disease globally. Through expert-led, evidence-based education, participants will gain actionable skills to monitor and assess Amyloid-Related Imaging Abnormalities (ARIA) in patients receiving anti-amyloid monoclonal antibodies.
Participants will gain actionable insights from expert faculty, who will explore:
- Pathophysiologic features that increase ARIA risk in patients using anti-amyloid monoclonal antibodies
- Standardized MRI protocols and grading scales to effectively detect and assess ARIA
- Best practices for interdisciplinary communication to improve coordination and care outcomes
Elevate your practice with cutting-edge insights into ARIA management, enabling you to enhance patience safety and care standards.
Speakers
Petrice M. Cogswell, MD, PhD
Chair, Neuroradiology Research
Mayo Clinic
Rochester, MN, USA
Dr. Cogswell is an Associate Professor of Radiology at Mayo Clinic in Rochester, MN. She is a diagnostic neuroradiologist and member of the Aging and Dementia Imaging Research Laboratory, which serves as the central MRI lab for multiple observational and therapeutic studies in Alzheimer’s disease. Her research interests include the temporal evolution of Alzheimer’s disease biomarkers and amyloid-related imaging abnormalities (ARIA).
Maria Vittoria Spampinato, MD
Assistant Professor, Radiology
Medical University of South Carolina
Charleston, SC, USA
Maria Vittoria Spampinato, MD is an academic radiologist and leader at the Medical University of South Carolina, a comprehensive academic health system serving South Carolina. In her dual role as the Vice Chair of Faculty Development and Neuroradiology Division Director, Dr. Spampinato’s mission is to advance neuroimaging services, to train the next generation of healthcare professionals, and to promote the academic advancement and well-being of the Radiology Faculty in alignment with MUSC Health’s strategic growth.
Dr. Spampinato has been a faculty member of the MUSC Department of Radiology for 19 years. Since assuming the role of Neuroradiology Division Director in 2013, Vittoria has led several initiatives that have improved the quality and safety of patient care, optimized resource utilization, and standardized imaging protocols across the MUSC Healthcare system. Vittoria’s research contributions have yielded 75 peer-reviewed publications. A dedicated educator, she has helped train over 110 radiology residents and 45 neuroradiology fellows, nine of whom are faculty members at MUSC.
Accreditation and Disclosure Information
Target Audience
This activity is designed for neuroradiologists, radiologists, and radiology residents dedicated to enhancing care for patients with Alzheimer’s disease globally.
Educational Objectives
After completing this activity, the participant should be better able to:
- Identify pathophysiologic features that put patients taking anti-amyloid monoclonal antibodies at increased risk for amyloid-related imaging abnormalities (ARIA)
- Apply standardized magnetic resonance imaging (MRI) protocols and grading scales to optimally monitor for, detect, and assess the severity of ARIA in patients receiving anti-amyloid monoclonal antibodies
- Integrate best practices for interdisciplinary communication to enhance coordination among radiology, neurology, and geriatrics in the management of ARIA
Agenda
- Is this ARIA?
- Pathophysiology and risk factors of ARIA
- Standardized MRI protocols and grading scales for ARIA detection
- Interdisciplinary communication for effective ARIA management
- Is this ARIA?
Accreditation, Support and Credit
This activity is provided by MLI
In support of improving patient care, Medical Learning Institute Inc is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
Medical Learning Institute Inc (MLI) designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
EBAC
This program is accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC®) for 1.0 hours of effective education time.
EBAC® holds an agreement on mutual recognition of substantive equivalency with the US Accreditation Council for CME (ACCME) and the Royal College of Physicians and Surgeons of Canada, respectively. Through an agreement between the European Board for Accreditation of Continuing Education for Health Professionals (EBAC®) and the American Medical Association, physicians may convert EBAC® External CME credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC® credit to AMA credit can be found on the AMA website. Other healthcare professionals may obtain from the AMA a certificate of participation in an activity eligible for conversion of credit to AMA PRA Category 1 Credit™.
EBAC® is a member of the International Academy for CPD Accreditation (IACPDA) and a partner member of the International Association of Medical Regulatory Authorities (IAMRA).
Note to EBAC® Participants: If you wish to receive an EBAC Certificate, you must complete another online evaluation. Upon completion, you will receive a code. Email this code to mvu@mlieducation.org and your certificate will be sent to you.
Support Statement
This activity is supported by an educational grant from Lilly.
Disclosure & Conflict of Interest Policy
Medical Learning Institute Inc is committed to providing high quality continuing education to healthcare professionals, as individuals and teams, with a protected space to learn, teach, and engage in scientific discourse free from influence from ineligible companies that may have an incentive to insert commercial bias into education. To that end, MLI requires faculty, presenters, planners, staff, and other individuals who are in a position to control the content of this CE activity to disclose all financial relationships they have had in the past 24 months with ineligible companies as defined by the ACCME, as related to the content of this CE activity, regardless of the amount or their view of the relevance to the education. All identified COI will be thoroughly vetted and mitigated according to MLI policy. These disclosures will be provided to learners prior to the start of the CE activity.
Faculty Disclosures
Planner/Presenter
Petrice M. Cogswell, MD, PhD
Chair, Neuroradiology Research
Mayo Clinic
Rochester, MN, USA
Petrice M. Cogswell, MD, PhD, has a financial interest/relationship or affiliation in the form of:
Consultant/Advisor: Eisai, Eli Lilly, Kaplan (all have ended)
Planner/Presenter
Maria Vittoria Spampinato, MD
Assistant Professor, Radiology
Medical University of South Carolina
Charleston, SC, USA
Maria Vittoria Spampinato, MD, has a financial interest/relationship or affiliation in the form of:
Research Funding: Siemens
All of the relevant financial relationships of individuals for this activity have been mitigated.
Planning Committee and Content/Peer Reviewers
The planners and content/peer reviewers from Medical Learning Institute Inc, the accredited provider, does not have any relevant financial relationships to disclose with ineligible companies unless listed below.
Disclosure of Unlabeled Use
This educational activity may contain discussions of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this CE activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the CE activity are those of the presenters and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this CE activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this CE activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Method of Participation
There are no fees for participating in or receiving credit for this CE activity. In order to receive credit, learners must participate in the entire CE activity, complete the activity evaluation form and your certificate of credit will be generated. A passing score of 70% or higher is needed to obtain credit. You will receive your certificate from Medical Learning Institute Inc.
For information on applicability and acceptance of continuing education credit for this CE activity, please consult your professional licensing board.
If you have questions regarding your certificate, please contact MLI at mvu@mlieducation.org.
About This Activity
Medical Learning Institute Inc is responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this CE activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of this activity is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of Medical Learning Institute Inc.
The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of Medical Learning Institute Inc or any of its partners, providers, and/or supporters.